CHLOE-PET CHerenkov Light mOdulE for time-of-flight Positron Emission Tomography
- Coordinator
- Instituto De Fisica De Altas Energias, Spain
- Runs
- 1 September 2023 to 31 August 2027
- Status
- Running
- EU funding
- €1.4m
- Total cost
- €1.4m
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101041972
What the project is doing
In the project's own words, from its summary on CORDIS.
Time-of-flight positron emission tomography (TOF-PET) is the standard-of-care in cancer detection. TOF-PET scanners’ performance is dependent on the radiation detectors they use. Improving time and spatial detection features in such detectors will dramatically impact the diagnostic capacity of TOF-PET systems. The goal of this project is to build a gamma detector concept for TOF-PET able to improve the time resolution and spatial segmentation of state-of-the-art detectors by a factor of up to 7 and 10, respectively, without additional production costs.
CHLOE-PET is a forward-looking gamma detector design for TOF-PET able to exploit the new photodetector technologies that are currently under development and will become available within the next 5-to-10 years. The novelty of the proposed design lies in using Cherenkov light as a prompt time source, using an innovative geometry optimized to maximize light collection, and employing photodetectors with small pixel pitch.
This project is the first attempt to build a detector module scalable to a full-size system that can be used in a hospital setting. The CHLOE-PET detector will consist of bismuth germanate (BGO) crystals with 12 mm thickness and will combine the readout of scintillation and Cherenkov light. CHLOE-PET will provide an effective 3D segmentation of 2x2x2 mm3, an intrinsic photon time spread of 20 ps, and no intrinsic radiation background (unlike state-of-the-art TOF-PET detectors).
Such improvements will allow increasing the signal-to-noise ratio of images by >2-fold, to be able to detect lesions of 2 mm size (>3 times the current performance), to build portable high-performance organ-dedicated TOF-PET systems, and to universalize the use of dynamic TOF-PET studies. The combination of these outcomes will provide significantly better diagnostic capabilities in a range of fields such as oncology, neurology, or cardiology, among others, and ultimately boost treatment efficacy and patient comfort.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Instituto De Fisica De Altas Energias | Cerdanyola Del Valles | Spain | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI